摘要
目的:探讨高血压社区规范化管理中抗高血压药物价格和经济可负担性情况。方法:采用世界卫生组织(World Health Organization,WHO)和国际健康行动机构(Health Action International,HAI)发展的标准化价格调查方法,对社区抗高血压药物价格可负担性进行评价。结果:无论城市或者农村地区,5大类抗高血压药物对于低收入人群不具有经济可负担性,17种抗高血压药物中约50%对于一般收入人群不具有经济可负担性,在城市地区不同药物费用差异最大的高达55.92倍,在农村地区不同药物费用差异最大的高达37.52倍。结论:高血压社区规范化管理中抗高血压药物的经济可负担性仍有待继续提高,不同收入人群抗高血压药物可负担性差异明显,药物治疗费用呈两极分化趋势,可负担性好的药物使用比例较高。
OBJECTIVE To explore the price and economic affordability of antihypertensive drug in hypertension community standardization management.METHODS The standardized price survey methodology developed by World Health Organization（WHO）and Health Action International（HAI）was used to evaluate the economic affordability of antihypertensive drug in community.RESULTS Whether in cities or in rural areas,5 classes of antihypertensive drugs were not economically affordable for the low-income people,and for the average-income people,about 50% of 17 kinds of antihypertensive drugs were not economically affordable,as well as,the biggest differences between drugs costs as high as 55.92 times in cities,the biggest differences between drug costs as high as 37.52 times in rural areas.CONCLUSION The economic affordability of antihypertensive drug in hypertension community standardization management remains to be improved continuously.Differences of affordability of antihypertensive drug among different income groups are obvious,and drug cost shows a trend of polarization,however,the use ratio of the drugs that own relatively better affordability is higher.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2014年第22期1951-1954,共4页
Chinese Journal of Hospital Pharmacy
